Robert Hsu

19PUBLICATIONS
62CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesNeurology and neuromuscular diseasesWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 28, 2026
Risk Stratification and Strategies Towards Front-Line Therapy of EGFR-Mutant NSCLC: A Narrative Review.

|Mar 05, 2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Robert Hsu, Karen Resnick, Peter Zang

|Feb 23, 2026
DIP-like Adenocarcinoma Presenting as a Part-Solid Nodule: A Case Report.

Natalia Brar, Robert Hsu, William D Wallace

|Jan 21, 2026
Updates on Antibody Drug Conjugates and Bispecific T-Cell Engagers in SCLC.

Kinsley Wang, Kyle Taing, Robert Hsu

|Dec 05, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry.

Sara A Walton, Justin J Kim, Francesco Paoloni

|Jul 24, 2025
Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

Justin J Kim, Sara A Walton, Navin R Mahadevan

Pageof 4

Frequent Collaborators

3 joint publications

Jorge Nieva

3 joint publications

David J Benjamin

2 joint publications

Sara A Walton

2 joint publications

Darin Poei